FetTech

FetTech is an FDA-cleared medical device company specializing in regenerative medicine solutions powered by its proprietary Multi-Tissue Platform (MTP) technology. The company develops innovative extracellular matrix (ECM) products that harness multiple tissue sources to support the body's natural healing processes across wound care, surgical applications, burns, and aesthetic procedures. FetTech's core product portfolio includes Stemsys Wound Powder, an FDA-cleared blend of extracellular matrices used in hospital and surgical settings for advanced wound healing, and ReyaGel, the first FDA-cleared liquid ECM formulation enabling applications in aesthetic, surgical, and hair restoration settings. The company is expanding into emerging therapeutic areas including inhalation therapies for respiratory recovery, targeted injection therapies, nerve regeneration for spinal cord repair, and antiviral therapies through its subsidiary Vyramed. Founded by pioneers in tissue engineering and wound care, FetTech operates as an independent, privately held organization focused on patient-centric innovation and accelerating recovery through biomimetic regenerative solutions.